Ubs Group Ag Lumira Dx LTD Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.24 - $0.48 $1,512 - $3,024	6,300 New	6,300 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.85 - $1.49 $11,477 - $20,119	13,503 New	13,503 $12,000
Q2 2022 Aug 10, 2022	SELL	$2.66 - $5.81 $6,740 - $14,722	-2,534 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.0 - $10.0 $15,066 - $25,110	2,511 Added 10917.39%	2,534 $15,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.49 $25,310 - $36,421	-3,472 Reduced 99.34%	23 $0
Q3 2021 Nov 15, 2021	BUY	$7.94 - $10.14 $27,750 - $35,439	3,495 New	3,495 $29,000

365K

Ticker LMDX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 170,688,000
Market Cap $1.71M
Description
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.